TABLE 1.

Patient data and characteristics of members of the S. sciuri group isolated from urine over a 3-year period

Patient	Age (yr)	Sexa	Symptoms of UTI	Hospitalized/outpatient	Underlying medical disorder	Antimicrobial treatment	Yr of isolation	Organism	Quantity (CFU/ml)	Culture type	Resistance to antibiotics
1	67	M	No	Outpatient	No	No	2000	S. sciuri	104	Pure	Erythromycin
2	71	F	No	Hospitalized	Diabetes mellitus	No	2000	S. sciuri	105	Pure	Tetracycline
3	35	M	No	Hospitalized	No	No	2000	S. sciuri	105	Pure	No
4	45	F	No	Outpatient	Calculus of kidney	No	2001	S. sciuri	104	Mixed (with novobiocin-susceptible CoNS)	No
5	25	F	No	Hospitalized	Pregnancy	No	2001	S. lentus	105	Pure	No
6	38	F	No	Outpatient	No	No	2001	S. sciuri	104	Mixed (with S. aureus)	No
7	80	F	No	Hospitalized	Diabetes mellitus	No	2001	S. lentus	105	Pure	No
8	31	F	No	Hospitalized	Calculus of kidney	No	2001	S. sciuri	106	Mixed (with novobiocin-susceptible CoNS)	No
9	58	F	No	Hospitalized	Unspecified chronic tubulo-interstitial nephritis	No	2001	S. vitulinus	104	Pure	No
10	70	F	No	Outpatient	No	No	2002	S. sciuri	105	Pure	No
11	63	F	No	Hospitalized	Hypertension	No	2002	S. sciuri	107	Mixed (with S. haemolyticus)	No
12	56	F	No	Outpatient	No	No	2002	S. vitulinus	105	Mixed (with E. coli)	No
13	46	M	Yes	Outpatient	Nephrostomy due to hydronephrosis with ureteropelvic junction obstruction	Amoxicillin-clavulanic acid	2002	S. lentus	105	Mixed (with Enterococcus faecalis)	Chloramphenicol, ciprofloxacin, and norfloxacin

^aM, male; F, female.